New nurse-led program to support women with early menopause after cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project develops and tests a nurse navigator–delivered intervention for women who experience premature or early menopause following cancer treatment. It follows a two-phase approach: first refining the program with input from survivors and clinicians, then piloting a randomized trial to assess feasibility and acceptability. Participants are randomized to receive the nurse navigator program or an educational control via video sessions and complete assessments at baseline and about 10 weeks later. The study emphasizes personalized education, decision support, self-efficacy, and cognitive-behavioral strategies for symptom management.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* female (biological sex);
* 18 to 44 years old;
* completed cancer treatment (other than endocrine therapy) \>12 months prior to enrollment;
* have not had a period for more than 12 months (amenorrhea);
* able to speak and read English.

Exclusion Criteria:

* diagnosis of metastatic cancer;
* visual or hearing impairment that would interfere with participation in study;
* cognitive impairment or severe mental illness that would interfere with participation in study.

Where it's running

• Duke Cancer Institute
  Durham, North Carolina, United States Recruiting

Study contacts

• Principal investigator: Rebecca Shelby, PhD — Duke University
• Study coordinator: Smrithi Divakaran, MPH
• Email: smrithi.divakaran@duke.edu
• Phone: 919-681-7695

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Estrogen therapy and heart health in women with POI

  This study tests whether starting estrogen replacement helps heart-health markers in women newly diagnosed with POI compared with healthy peers.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT06866119

• Improving Medication Adherence for Recently Diagnosed Cancer Patients

  This pilot tests whether a pharmacist-led program plus the Medisafe app helps people with newly diagnosed cancer who take multiple medicines stick to their treatment plans.

  Recruiting Duke University · Durham, North Carolina · NCT07811258

• emPath platform pilot to link and keep adults with opioid use disorder in care in Durham

  This pilot tests a mobile app and telemedicine approach to help adults with opioid use disorder start and stay in MOUD through community outreach in Durham, NC.

  Recruiting Duke University · Durham, North Carolina · NCT07810322

• FlexED: A digital program to help young women see thoughts and feelings about their body in a friendlier way

  This trial tests a smartphone-based, gamified ACT-inspired program called FlexED to help young women and girls at risk for eating disorders see how they think and feel about their bodies, and to see if it can be feasibly spread to more people.

  Recruiting Duke University · Durham, North Carolina · NCT07807774

• Removing the ripcord from a glaucoma drainage device after 3 months

  This study tests whether removing the ripcord from an implanted glaucoma drainage device changes eye pressure for adults with open-angle glaucoma.

  Recruiting Duke University · Durham, North Carolina · NCT07803536

• Lupus Nephritis Care Pathway

  A small group of adults with lupus nephritis will try a team-based care path that uses telemedicine and pharmacist-led support to help manage their treatment and see if it improves adherence and outcomes.

  Recruiting Duke University · Durham, North Carolina · NCT07783152

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.